Identification of a biomarker panel for colorectal cancer diagnosis

BMC Cancer

Volumn 12, Issue , 2012, Pages

  García Bilbao, Amaia ^a   Armañanzas, Rubén ^b   Ispizua, Ziortza ^a   Calvo, Begoña ^c   Alonso Varona, Ana ^d   Inza, Iñaki ^d   Larrañaga, Pedro ^b   López Vivanco, Guillermo ^c   Suárez Merino, Blanca ^a   Betanzos, Mónica ^a  

^a Centro Tecnologico Gaiker   (Spain)

^b UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; BAYES THEOREM; BIOINFORMATICS; BOOTSTRAPPING; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CLASSIFICATION; COHORT ANALYSIS; COLORECTAL CANCER; CONSENSUS; CONTROLLED STUDY; DATA ANALYSIS; GENETIC DATABASE; GENOMICS; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; MICROARRAY ANALYSIS; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLING; TISSUE SECTION; UNINDEXED SEQUENCE; ANALYSIS OF VARIANCE; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC VARIABILITY; GENETICS; REAL TIME POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; BAYES THEOREM; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC VARIATION; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84859576123     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-43     Document Type: Article

References (53)

1. Bandres E, Zarate R, Ramirez N, Abajo A, Bitarte N, García-Foncillas J. Pharmacogenomics in colorectal cancer: the first step for individualized-therapy. World J Gastroenterol 2007, 13(44):5888-5901.
2. Kim H-J, Yu M-H, Kim H, Byun J, Lee CH. Non-invasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 2008, 41(10):685-692. 10.5483/BMBRep.2008.41.10.685, 18959813.
3. Fearon ER, Vogelstein B. A Genetic Model for Colorectal Tumorigenesis. Cell 1990, 61:759-767. 10.1016/0092-8674(90)90186-I, 2188735.
4. Henley SJ, King JB, German RR, Richardson LC, Plescia M. Surveillance of screening--detected cancers (colon and rectum, breast, and cervix)--United States, 2004-2006. MMWR Morb Mortal Wkly Rep 2010, 59(SS-9):1-26.
5. Richardson LC, Rim SH, Plescia M. Div of Cancer Prevention and Control NCCDPaHP, CDC: Vital Signs: Colorectal Cancer Screening Among Adults Aged 50-75 years MMWR. Morb Mortal Wkly Rep 2010, 59(26):808-812.
6. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008, 149:638-658.
7. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010, 60:99-119. 10.3322/caac.20063, 20228384.
8. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, Fric P. Colorectal cancer screening in Europe. World J Gastroenterol 2009, 15(47):5907-5915. 10.3748/wjg.15.5907, 2795177, 20014454.
9. Burch JA, Soares-Weiser K, St John DJ, Duffy S, Smith S, Kleijnen J, Westwood M. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 2007, 14(3):132-137. 10.1258/096914107782066220, 17925085.
10. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult blood tests for colorectal-cancer screening. N Engl J Med 1996, 334(3):155-159. 10.1056/NEJM199601183340304, 8531970.
11. Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, Sadowski D, Sudduth R, Zuckerman GR, Rockey DC. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 2000, 95(5):1331-1338. 10.1111/j.1572-0241.2000.02032.x, 10811348.
12. Newton KF, Newman W, Hill J. Review of biomarkers in colorectal cancer. Colorectal Disease 2012, 14(1):3-17. 10.1111/j.1463-1318.2010.02439.x, 21040359.
13. Winawer S, Fletcher R, Rex D, Bond J, Burt RW, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterol 2003, 124:544-560.
14. Greenen JE, Schmitt MG, Wu WC, Hogan WJ. Major complications of colonoscopy: bleeding and perforation. Am J Dig Dis 1975, 20:231-235. 10.1007/BF01070726, 804812.
15. Bates J. The discovery of cancer biomarkers. Cancer biomarkers: adoption is driving growth 2008, 12-28. Needham, USA: Cambridge Healthtech Institute, [Insight Pharma Reports].
16. Tanaka T, Tanaka M, Tanaka T, Ishigamori R. Biomarkers for colorectal cancer. Int J Mol Sci 2010, 11(9):3209-3225. 10.3390/ijms11093209, 2956090, 20957089.
17. Jain KK. Cancer biomarkers: current issue and future directions. Curr Opin Mol Ther 2007, 9:563-571.
18. De Roock W, Biesmans B, De Schutter J, Tejpar S. Clinical biomarkers in oncology: Focus on colorectal cancer. Molecular diagnosis & Therapy 2009, 13(22):103-114. (112), 3263980, 22282704.
19. Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, et al. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Clin Cancer Res 2008, 14:455-460. 10.1158/1078-0432.CCR-07-1801, 18203981.
20. Zhang S, Gant JW. Effect of pooling samples on the efficiency of comparative studies using microarrays. Bioinformatics 2005, 21(24):4378-4383. 10.1093/bioinformatics/bti717, 16234321.
21. Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Asp Med 2006, 27:126-139.
22. Wolber PK, Collins PJ, Lucas AB, De Witte A, Shannon KW. The Agilent in situ-synthesized microarray platform. Methods Enzymol 2006, 410:28-57.
23. Chen Y, Kamat V, Dougherty ER, Bittner ML, Meltzer PS, Trent JM. Ratio statistics of gene expression levels and applications to microarray data analysis. Bioinformatics 2002, 18(9):1207-1215. 10.1093/bioinformatics/18.9.1207, 12217912.
24. Dudoit S, Hwe Yang Y, Callow MJ, Speed TP. Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Statistica Sinica 2002, 12:111-139.
25. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB. Missing value estimation methods for DNA microarrays. Bioinformatics 2001, 17(6):520-525. 10.1093/bioinformatics/17.6.520, 11395428.
26. Duval B, Hao JK. Advances in metaheuristic for gene selection and classification of microarray data. Brief Bioinform 2009, 2(1):127-141.
27. Armañanzas R, Calvo B, Inza I, López-Hoyos M, Martínez-Taboada V, Ucar E, Bernales I, Fullaondo A, Larrañaga P, Zubiaga AM. Microarray analysis of autoimmune diseases by machine learning procedures. IEEE Trans Inf Technol Biomed 2009, 13(3):341-350.
28. Saeys S, Inza I, Larrañaga P. A review of feature selection techniques in bioinformatics. Bioinformatics 2007, 23(19):2507-2517. 10.1093/bioinformatics/btm344, 17720704.
29. Abeel T, Halleputte T, van de Peer Y, Dupoint P, Saeys Y. Robust biomarker identification for cancer diagnosis with ensemble feature selection methods. Bioinformatics 2010, 26(3):392-398. 10.1093/bioinformatics/btp630, 19942583.
30. Armañanzas R, Inza I, Larrañaga P. Detecting reliable gene interactions by hierachy of Bayesian network classifiers. Comput Methods Programs Biomed 2008, 91:110-121. 10.1016/j.cmpb.2008.02.010, 18433926.
31. Sahami M. Learning limited dependence Bayesian classifiers. Proceedings of the Second International Conference on Knowledge Discovery and Data Mining: 2-4 August 1996; Portland 1996, 335-338. Menlo Park: The AAAI Press, Simoudis E, Han J, Fayyad U.
32. Hall MA, Smith LA. Feature subset selection: a correlation based filter approach. Proceedings of the Fourth International Conference of Neural Information Processing and Intelligent Information Systems: 1997; Dunedin 1997, 855-858. Springer. Berlin.
33. Ancona N, Maglietta R, Piepoli A, D'Addabbo A, Cotugno R, Savino M, Liuni S, Carella M, Pesole G, Perri F. On the statistical assesment of classifiers using DNA microarray data. BMC Bioinforma 2006, 7:387.
34. Bishop CM. Pattern recognition and machine learning. 2006,
35. Liang XQ, Avraham HK, Jiang S, Avraham S. Genetic alterations of the NRP/B gene are associated with human brain tumors. Oncogene 2004, 23(55):5890-5900.
36. Kim TA, Lim J, Ota S, Raja S, Rogers R, Rivnay B, Avraham HK, Avraham S. NRP/B, a novel nuclear matrix protein associates with p110 (RB) and is involved in neuronal differentiation. J Cell Biol 1998, 141(13):553-566. 2132755, 9566959.
37. Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M, Nakamura Y. Up-regulation of the Ectodermal-Neural Cortex 1 (ENC1) Gene, a downstream target of the b-catenin/T-cell factor complex, in colorectal carcinomas. Cancer Res 2001, 61:7722-77726.
38. Smith JL, Rangaraj K, Simpson R, Maclean DJ, Nathanson LK, Stuart KA, Scott SP, Ramm GA, de Jersey J. Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. J Lipid Res 2004, 45(4):686-696. 10.1194/jlr.M300365-JLR200, 14729857.
39. Oh-Hashi K, Imai K, Koga H, Hirata Y, Kiuchi K. Knockdown of transmembrane protein 132A by RNA interference facilitates serum starvation induced cell death in Neuro2a cells. Mol Cell Biochem 2010, 342(1-2):117-123. 10.1007/s11010-010-0475-9, 20455009.
40. Ogawa H, Binion DG, Heidemann J, Theriot M, Fisher PJ, Johnson NA, Otterson MF, Rafiee P. Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells. Am J Physiol Cell Physiol 2005, 288(2):C272-C281. 10.1152/ajpcell.00406.2003, 15483224.
41. Mlecnik B, Tosolini M, Charoentong P, Krilovsky A, Bindea G, Berger A, Camus M, Gillard M, Bruneval P, Fridman WH, et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterol 2010, 138(4):1429-1440.
42. Prosniak M, Dierov J, Okami K, Tilton B, Jameson B, Sawaya BE, Gartenhaus RB. A novel candidate oncogene, MCT-1, is involved in cell cycle progression. Cancer Res 1998, 58(19):4233-4237.
43. Laitinen J, Saris P, Holtta E, Pettersson I. U2-snRNP B" protein gene is an early growth-inducible gene. J Cell Biochem 1995, 58(4):490-498. 10.1002/jcb.240580412, 7593271.
44. Rozanov DV, Savinov AY, Williams R, Liu K, Golubkov VS, Krajewski S, Strongin AY. Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. Cancer Res 2008, 68(11):4086-4096. 10.1158/0008-5472.CAN-07-6458, 2659615, 18519667.
45. Dai MS, Zeng SX, Jin Y, Zun XX, David L, Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 2004, 24(17):7654-7668. 10.1128/MCB.24.17.7654-7668.2004, 506971, 15314173.
46. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. BioTechniques 1999, 26:112-122.
47. Cappellani A, Zanghi A, Di Vita M, Zanet E, Veroux P, Cacopardo B, Cavallero A, Piccolo G, Lo Menzo E, Merabito P, et al. Clinical and biological markers in gastric cancer: update and perspectives. Front Biosci 2010, 2:403-412.
48. Sikaroodi M, Galachiantz Y, Baranova A. Tumor markers: the potential of "omics" approach. Curr Mol Med 2010, 10(2):249-257. 10.2174/156652410790963277, 20196723.
49. Stone M. Cross-Validatory Choice and Assessment of Statistical Predictions. Journal of the Royal Statistical Society Series B 1974, 36:111-147.
50. Kraus S, Arber N. Inflammation and colorectal cancer. Curr Opin Pharmacol 2009, 9(4):405-410. 10.1016/j.coph.2009.06.006, 19589728.
51. Saaf AM, Halbleib JM, Chen X, Yuen ST, Leung SY, Nelson WJ, Brown PO. Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol Biol Cell 2007, 18(11):4245-4260. 10.1091/mbc.E07-04-0309, 2043540, 17699589.
52. Horowitz MP. Regulation of transcription by the retinoblastoma protein. Genes Chromosomes Cancer 1993, 6(2):124-131. 10.1002/gcc.2870060211, 7680889.
53. Lee O, Chang CC, Lee W, Chang TY. Immunodepletion experiments suggest that acyl-coenzyme A:cholesterol Acyltransferase-1 (ACAT1) protein plays a mayor catalytic role in adult human liver, adrenal gland, macrophages and kidney, but not in intestines. J Lipid Res 1998, 39(8):1722-1727.